Critically Ill Pediatric Patient and SARS-CoV-2 Infection

In December 2019 SARS-CoV-2 initiated a worldwide COVID-19 pandemic, which is still ongoing in 2022. Although adult elderly patients with chronic preexisting diseases had been identified as the most vulnerable group, COVID-19 has also had a significant impact on pediatric intensive care. Early in 2020, a new disease presentation, multisystemic inflammatory syndrome, was described in children. Despite the vaccination that is available for all age categories, due to its selection process, new viral mutations and highly variable vaccination rate, COVID-19 remains a significant clinical challenge in adult and pediatric intensive care in 2022.

Automated summary

In December 2019, SARS-CoV-2 initiated a global COVID-19 pandemic, which still continues in 2022. COVID-19 has had a significant impact on pediatric intensive care, with the emergence of multisystemic inflammatory syndrome in children. Despite the availability of vaccines for all age groups, COVID-19 remains a major clinical challenge in adult and pediatric intensive care in 2022, due to new viral mutations and variable vaccination rates.